Clin2
NCT06821126Possibly a fitRecruiting

Nasal spray COVID-19 vaccine booster study for healthy adults

Healthy

Part of Infections, Lungs & breathing clinical trials.

This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
238 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old (phase 1) or 60 years old (phase 2).
  • You have a body mass index (BMI) between 18.5 and 30, meaning a healthy weight range.
  • You have already had at least 3 doses of an mRNA COVID-19 vaccine, with your last booster at least 6 months ago. Or you had 2 mRNA doses and a confirmed COVID infection at least 6 months ago.
  • You are in good general health, with no serious medical conditions like chronic rhinitis (stuffy nose), nasal problems, or a history of nosebleeds.
  • You are available to stay near the study site for the whole trial and agree to use barrier methods (like masks and hand washing) against COVID-19.
  • If you are a woman who can become pregnant, you must use highly effective birth control and not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07536308Recruiting· Phase 1
Nasal COVID-19 booster vaccine safety trial

This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.

Decatur, Georgia
NCT07703475Not yet recruiting· Phase 1
Nasal spray booster for covid-19 vaccine

This study tests a new nasal spray booster vaccine for COVID-19. It looks at safety and how well it boosts your immune system. If you've had your primary shots and a booster, this might help improve your protection.

New York, New York
NCT07852208Not yet recruiting· Phase 1
Safety of a nasal spray in healthy adults

This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.

Randwick, New South Wales
NCT07605520Recruiting· Early Phase 1
COVID-19 Booster Vaccine Study for Previously Vaccinated Adults

This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.

Créteil
NCT06768697Not yet recruiting· Early Phase 1
Nasal spray boost for COVID-19 immunity

This trial tests a nasal spray that may boost your immune system against COVID-19. It's for people who had the COVID-19 vaccine at least 6 months ago and haven't had COVID-19 recently.

Shanghai, Jinshan District
NCT07640308Not yet recruiting· Phase 1
New mRNA booster for covid-19

This study tests a new booster vaccine against COVID-19 that uses mRNA technology, similar to the Pfizer or Moderna shots. If you've already had your primary series and a booster, this could help keep your immunity strong.

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.